Loading…

Comparison of outcomes for short-neck and juxtarenal aortic aneurysms treated with the Nellix endograft versus conventional endovascular aneurysm sealing

Abstract Objective The objective of this study was to evaluate the results of the off-label use of the Nellix endograft (Endologix, Irvine, Calif) for the treatment of short-neck aneurysms and juxtarenal aortic aneurysms (JAAs) compared with the outcomes of patients with infrarenal abdominal aortic...

Full description

Saved in:
Bibliographic Details
Published in:Journal of vascular surgery 2017-11, Vol.66 (5), p.1371-1378
Main Authors: Psacharopulo, Daniele, MD, Ferri, Michelangelo, MD, Ferrero, Emanuele, MD, Bahia, Sandeep S., MBBS, Viazzo, Andrea, MD, Pecchio, Alberto, MD, Ricceri, Fulvio, PhD, Nessi, Franco, MD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Objective The objective of this study was to evaluate the results of the off-label use of the Nellix endograft (Endologix, Irvine, Calif) for the treatment of short-neck aneurysms and juxtarenal aortic aneurysms (JAAs) compared with the outcomes of patients with infrarenal abdominal aortic aneurysms treated in accordance with the manufacturer's instructions for use. Methods Data available from patients treated with the Nellix endograft from September 2013 to January 2016 were reviewed to create a case-control analysis (1:2). Fourteen elective patients with a short-neck aneurysm or JAA (
ISSN:0741-5214
1097-6809
DOI:10.1016/j.jvs.2017.03.444